/NXGL
NEXGEL, Inc.
NXGL • NASDAQNXGL • NASDAQ • Healthcare
$0.96+15.82%+0.13
$0.96+15.82%(+0.13)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
70Bullish
Risk
95Low Risk
Momentum
0Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
31.6%▲22.5pp
Revenue after COGS
Operating
-40.9%▲44.1pp
After operating expenses
Net
-37.8%▲39.4pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
-8.9
Price vs earnings
EV/EBITDA
-10.4
Enterprise value
FCF Yield
-14.8%
Cash generation
Earnings Yield
-11.3%
Inverse of P/E
Capital Efficiency
-43
GoAI Quality ScorePoor
ROEReturn on Equity
-57.0%Weak
ROAReturn on Assets
-29.9%Weak
ROICReturn on Invested Capital
-39.9%Weak
Financial Health
Current RatioHealthy
2.07
Short-term solvency (>1.5)
Net Debt / EBITDANet Cash
-0.35x
Debt repayment capacity (<3x)
Income QualityStrong
1.18
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $8.69M | $4.09M | $2.05M | $1.55M | $674.00K |
| Gross Profit | $2.75M | $374.00K | $256.00K | $8.00K | -$291.00K |
| Gross Margin | 31.6% | 9.1% | 12.5% | 0.5% | -43.2% |
| Operating Income | -$3.55M | -$3.48M | -$3.35M | -$2.57M | -$2.26M |
| Net Income | -$3.28M | -$3.16M | -$4.75M | -$4.31M | -$2.26M |
| Net Margin | -37.8% | -77.2% | -231.7% | -277.9% | -335.9% |
| EPS | -$0.50 | -$0.56 | -$0.85 | -$0.77 | -$0.41 |
Rating Distribution
Strong Buy
0
0%
Buy
1
100%
Hold
0
0%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Maxim Group● Maintain
Buy
2022-02-25Earnings History & Surprises
BEAT RATE
50%
Last 16 quarters
AVG SURPRISE
-59.3%
EPS vs Estimate
BEATS / MISSES
8/7
1 met exactly
LATEST EPS
$-0.08
Q4 '25
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q4 '25
+11.1%
$-0.08 vs $-0.09
Q3 '25
-800.0%
$-0.09 vs $-0.01
Q2 '25
+10.0%
$-0.09 vs $-0.10
Q1 '25
+20.0%
$-0.08 vs $-0.10
Q4 '24
-10.0%
$-0.11 vs $-0.10
Q3 '24
$-0.14 vs $-0.14
Q2 '24
+22.2%
$-0.14 vs $-0.18
Q2 '24
-72.7%
$-0.19 vs $-0.11
Q4 '23
+16.7%
$-0.10 vs $-0.12
Q3 '23
+7.7%
$-0.12 vs $-0.13
Q2 '23
-7.1%
$-0.15 vs $-0.14
Q1 '23
+26.7%
$-0.11 vs $-0.15
No investor questions available.
Latest News
No news available